Kelly A. Kramer - May 7, 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Director
Signature
/s/ Edward S. Son by by Power of Attorney for Kelly A. Kramer
Stock symbol
GILD
Transactions as of
May 7, 2025
Transactions value $
$0
Form type
4
Date filed
5/8/2025, 08:17 PM
Previous filing
Jul 3, 2024
Next filing
Jun 17, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kramer Kelly A. Director 333 LAKESIDE DRIVE, FOSTER CITY /s/ Edward S. Son by by Power of Attorney for Kelly A. Kramer 2025-05-08 0001629885

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Award $0 +1.52K +8.62% $0.00 19.1K May 7, 2025 Common Stock 1.52K Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +6.81K $0.00 6.81K May 7, 2025 Common Stock 6.81K $98.90 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 100% of the restricted stock units vested immediately upon the grant date of May 7, 2025.
F3 100% of the shares subject to the stock option vested immediately upon the grant date of May 7, 2025.